Aug 11, 2026 09:36AM
May 20, 2026 07:29AM
May 20, 2026 06:47AM
May 14, 2026 06:05AM
Mar 10, 2026 04:03PM
Mar 10, 2026 09:54AM
Mar 4, 2026 03:03AM JPMorgan Starts Protera Therapeutics (TARA) at Overweight
Mar 4, 2026 03:03AM
Feb 23, 2026 05:06PM
Jan 12, 2026 07:01AM
Jan 7, 2026 03:46AM
Nov 20, 2025 06:41AM
Nov 20, 2025 06:02AM
Nov 10, 2025 05:02PM Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 7c
Oct 9, 2025 06:43AM
Oct 6, 2025 06:50AM
Aug 11, 2025 08:59AM
Jun 30, 2025 08:10AM
Jun 2, 2025 04:04PM
May 8, 2025 05:19PM
Apr 28, 2025 12:32PM Protara Therapeutics (TARA) Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
Apr 15, 2025 04:14PM
Apr 10, 2025 04:07PM
Mar 19, 2025 08:03AM
Mar 14, 2025 06:06AM
Mar 6, 2025 07:26AM
Mar 5, 2025 08:02AM
Dec 9, 2024 04:01PM Protara Therapeutics (TARA) Announces Proposed Public Offering
Dec 6, 2024 06:49AM
Dec 5, 2024 11:08AM
Dec 5, 2024 07:01AM
Nov 12, 2024 08:10AM
Oct 21, 2024 08:02AM
Sep 12, 2024 06:18AM
Sep 9, 2024 02:22PM TD Cowen Reiterates Buy Rating on Protera Therapeutics (TARA)
Sep 9, 2024 08:05AM
Aug 6, 2024 02:01PM
Aug 6, 2024 09:46AM

444,182 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All